The involvement of ADAR1 in antidepressant action by regulating BDNF via miR-432

X Zhang, Y Xue, J Li, H Xu, W Yan, Z Zhao, W Yu… - Behavioural Brain …, 2021 - Elsevier
Brain-derived neurotrophic factor (BDNF) is a biomarker of depression. Recent studies have
found adenosine deaminase acting on RNA1 (ADAR1) is a novel target being sensitive to …

Genetic variations of ionotropic glutamate receptor pathways on interferon-α-induced depression in patients with hepatitis C viral infection

SW Cheng, JX Li, YC Chien, JPC Chang… - Brain, Behavior, and …, 2021 - Elsevier
Importance The most supportive evidence of the inflammation theory of depression is that up
to one-third of patients with Hepatitis C virus infection (HCV) develop clinical depressive …

The west meets the east–A need for a renaissance in brain, behavior, and immunity research

SK Satyanarayanan, H Su, HJ Park, KP Su - Brain, Behavior, and Immunity, 2023 - Elsevier
Psychoneuroimmunology (PNI)—the burgeoning concept in recent years, can potentially
contribute to developing effective treatments for mental health disorders. Despite the …

Predictive genetic variations in the kynurenine pathway for interferon-α-induced depression in patients with hepatitis C viral infection

SW Cheng, JX Li, DTL Chen, YC Chien… - Journal of Personalized …, 2021 - mdpi.com
Importance: The high incidence of major depressive episodes during interferon-α (IFN-α)
therapy is considered the most powerful supportive evidence for the inflammation theory of …

Protective Effect of Interferon-based Antiviral Therapy on Risk of Bipolar Disorder in Patients with Hepatitis C Virus Infection: A Nationwide Longitudinal Study

MH Chen, SJ Tsai, TJ Chen - Taiwanese Journal of Psychiatry, 2022 - journals.lww.com
Background: A recent study has shown the beneficial effects of interferon (IFN)-based
antiviral therapy (AVT) in reducing the risk of newly diagnosed depression among patients …

Wskaźniki stanu zapalnego w depresji.

WG Wiese, A Cichocka… - Psychiatry …, 2022 - search.ebscohost.com
Depression is one of the leading causes of disability worldwide, and 15% of patients with
depression commit suicide. One of the milestones in the diagnosis and treatment of …

Somatic symptoms in inflammation-related depression: Reply to" Letter for depression-free after interferon-α exposure indicates less incidence of depressive disorder …

CF Sun, WC Chiu, KP Su - Brain, behavior, and immunity, 2022 - pubmed.ncbi.nlm.nih.gov
Somatic symptoms in inflammation-related depression: Reply to "Letter for depression-free
after interferon-α exposure indicates less incidence of depressive disorder: A longitudinal …

Depression-free after interferon-a exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan

PS Liu, YP Liaw - Brain, behavior, and immunity, 2022 - pubmed.ncbi.nlm.nih.gov
Depression-free after interferon-a exposure indicates less incidence of depressive disorder: A
longitudinal study in Taiwan Depression-free after interferon-a exposure indicates less …

Does the decreased incidence of new-onset depression in patients with interferon-α therapy indicate the protective effect of interferon-α against depression?

T Saito, M Ikeda, S Hashimoto… - Brain, Behavior, and …, 2021 - pure.fujita-hu.ac.jp
Does the decreased incidence of new-onset depression in patients with interferon-α therapy
indicate the protective effect of interferon-α against depression? — 藤田医科大学 メイン …

Reply to" Does the decreased incidence of new-onset depression in patients with interferon-α therapy indicate the protective effect of interferon-α against depression?"

CF Sun, WC Chiu, KP Su - Brain, behavior, and immunity, 2021 - pubmed.ncbi.nlm.nih.gov
Reply to "Does the decreased incidence of new-onset depression in patients with interferon-α
therapy indicate the protective effect of interferon-α against depression?" Reply to "Does the …